BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers
- 6 December 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 57 (1) , 1-23
- https://doi.org/10.1016/j.critrevonc.2005.05.003
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- The BOADICEA model of genetic susceptibility to breast and ovarian cancerBritish Journal of Cancer, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragmentsHuman Mutation, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genesBritish Journal of Cancer, 2002
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Transcriptional activation functions in BRCA2Nature, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995